FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Clears 2 Wound Dressings from 3M Health

FDA clears two 510(k)s from 3M Health Care for its 3M Veraflo Cleanse Choice Complete Dressing and 3M VAC Veraflo Cleanse Choice Dressing.

latest-news-card-1
Animal Drugs

CVM Electronic Submission Registration

FDA publishes a guidance with general standards for registering with the CVM electronic submission system.

latest-news-card-1
Human Drugs

DefenCath NDA to be Resubmitted by Mid-May

CorMedix says it will resubmit an NDA for its DefenCath within the next few weeks.

latest-news-card-1
Human Drugs

Nonrandom Data Can Emulate Random Trials: Study

Harvard Medical School researchers say it is possible for database studies to emulate randomized clinical trials to show how medications work in clini...

latest-news-card-1
Human Drugs

Iptacopan FDA Submission Coming Soon: Novartis

Novartis says it is planning a regulatory submission to FDA and other agencies worldwide in the first half of this year for iptocopan to treat paroxys...

latest-news-card-1
Federal Register

Animal Drug User Fee Info Collection

Federal Register notice: FDA seeks comments on an information collection extension Animal Drug and Animal Generic Drug User Fee Programs.

latest-news-card-1
Human Drugs

Alvotech FDA-483 Released

FDA releases the form FDA-483 with eight observations from an inspection at Reykjavik, Iceland-based Alvotech Hf.

latest-news-card-1
Human Drugs

Bankrupt Akorn Recalls All Products

Akorn through its bankruptcy (Chapter 7) trustee recalls various within-expiry human and animal products because the company has ceased all operations...

latest-news-card-1
Human Drugs

Vertex Gains Expanded Use for Cystic Fibrosis Drug

FDA approves a Vertex Pharmaceuticals supplemental NDA for the expanded use of Trikafta (elexacaftor/tezacaftor/ivacaftor) to include certain children...

latest-news-card-1
FDA General

FDA Warning on Androgen Receptor Modulators

FDA issues a warning about adverse event reports related to selective androgen receptor modulators (SARMs), which are often marketed as dietary supple...